The superior antitumor effect of sgCas9‐AdV/Gel than anti‐PD‐L1 can be attributed to the permanent silence of PD‐L1 expression to overcome the immune resistance/invasion of cancer cells through repopulating the intracellular PD‐L1 to cell surface. The gene discussed is CD274; the disease is cancer.